Protalix Biotherapeutics, Inc. (PLX)
1.975
+0.02
(+0.77%)
USD |
NYAM |
Jun 09, 16:00
1.98
0.00 (0.00%)
After-Hours: 17:56
Protalix Biotherapeutics Profit Margin (Quarterly) : 54.27% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -- |
| Altimmune, Inc. | -- |
| Humacyte, Inc. | -3.56K% |
| Amgen, Inc. | 21.02% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 29.10% |
| Return on Assets | 18.28% |
| Return on Invested Capital | 25.64% |
| Gross Profit Margin (Quarterly) | 87.77% |
| Operating Margin (Quarterly) | 62.65% |
| Return on Net Operating Assets | 35.40% |